In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains | Zendy

Susanne Jacobsson | Zendy; Daniel Golparian | Zendy; Ly Phan | Zendy; Makoto Ohnishi | Zendy; Hans Fredlund | Zendy; Yat Sun Or | Zendy; Magnus Unemo | Zendy

Open Access

In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains

Author(s) -

Susanne Jacobsson,

Daniel Golparian,

Ly Phan,

Makoto Ohnishi,

Hans Fredlund,

Yat Sun Or,

Magnus Unemo

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku344

Subject(s) - neisseria gonorrhoeae , microbiology and biotechnology , antimicrobial , in vitro , neisseriaceae , biology , neisseria , antibiotics , virology , bacteria , genetics

New antimicrobials are essential to prevent gonorrhoea becoming an untreatable infection. Herein, the in vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against Neisseria gonorrhoeae strains were investigated and compared with antimicrobials currently or previously recommended for treatment of gonorrhoea.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research